Psychedelic Integration Therapy
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Faculty
Dr. Kelan Thomas
Course Description
This reading and study group will maintain the same membership for the 12-week period. The group will have a syllabus with readings that participants will be expected to read prior to each discussion group meeting. The format for each session will include a short review of each paper by the group leader, followed by a discussion of the content and group members’ perspectives of the topic. This is an active group and weekly participation is required. The group is ideal for clinicians, graduate students, researchers, or the public, so long as they have training or interest in the biological responses that may influence the efficacy and safety of psychedelic therapy. Readings will include publications in the academic literature. The articles will provide an overview of psychedelic effects investigated by a variety of scientific methods (pharmacodynamics, pharmacokinetics, pharmacogenomics, neuroscience) for several types of psychedelics (e.g., psilocybin, ayahuasca, MDMA, ketamine).
A limited number of Diversity Fund scholarships are available, please complete this application, in addition to the course application.
Learning Objectives
At the end of this course, the participant will be able to:
- Describe pharmacokinetic properties of psilocybin to predict potential drug interactions and adverse effects
- Describe pharmacokinetic properties of ayahuasca to predict potential drug interactions and adverse effects
- Describe pharmacokinetic properties of MDMA to predict potential drug interactions and adverse effects
- Describe pharmacokinetic properties of ketamine to predict potential drug interactions and adverse effects
- Explain how the pharmacodynamics of psilocybin affects clinical and serological biomarkers
- Explain how the pharmacodynamics of ayahuasca affects clinical and serological biomarkers
- Explain how the pharmacodynamics of MDMA affects clinical and serological biomarkers
- Explain how the pharmacodynamics of ketamine affects clinical and serological biomarkers
- Discuss the effects of psilocybin on neural network function
- Discuss the effects of ayahuasca on neural network function
- Discuss the effects of MDMA on neural network function
- Discuss the effects of ketamine on neural network function
Perks
- Registration includes access to our online classroom, course handouts, and private course discussion board. All attendees may opt to be added to our professional community email list of over 800 professionals who have completed this (or similar) courses with us.
Other Dates for this Course
Upcoming Events
Oct 4, 2021 - Dec 20, 2021
8:00 - 9:30 PM ET
Dr. Kelan Thomas
Other Upcoming Courses
Psychological Approaches to Psychedelic Therapy, Fall 2021 | Online
A Reading & Study Group teaching focusing on various psychological concepts central to psychedelic therapy.
Sep 17, 2021 - Dec 10, 2021
10:00 - 11:30 AM ET
Andrew Rose
Psychedelics and Psychoanalysis, Fall 2021 | Online
This Reading & Study Group uses contemporary and historical sources to teach the numerous ways psychoanalysis and psychedelics have been, and are, involved with one another.
Sep 22, 2021 - Dec 15, 2021
10:00 - 11:30 AM ET
Dr. Jeffrey Guss
Access and Inclusion in Psychedelic Treatment | Webinar Series
This 10-week webinar series explores the present challenges and future opportunities for addressing social injustice in the field of psychedelic medicine, focusing on the role of the clinician’s voice in context of the larger healthcare system.
Sep 23, 2021 - Dec 9, 2021
7:30 - 8:45 PM ET
Kelly Sykes, PhD, Dr. Elizabeth Nielson, Alexander Camargo, PsyD
Psychoanalytic Psychedelic Clinical Consultation Group, Fall 2021, Section 2 | Online
The goal of this group is to provide a safe, informative and confidential place for therapists and other practitioners to discuss their clinical work in psychedelic integration.
Sep 23, 2021 - Dec 16, 2021
12:00 - 1:30 PM ET
Dr. Jeffrey Guss
Psychedelic Integration: Premise and Promise, Fall 2021 | Online
Fluence's foundational course is designed for those who want to learn about Psychedelic Harm Reduction and Integration clinical practice.
Oct 1, 2021 - Oct 3, 2021
10:00 AM - 3:00 PM EDT
Dr. Elizabeth Nielson, Dr. Ingmar Gorman
Psychedelics Psychopharmacology, Fall 2021 | Online
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Oct 4, 2021 - Dec 20, 2021
8:00 - 9:30 PM ET
Dr. Kelan Thomas
Mindfulness Based Stress Reduction for Psychedelic Therapists | Fall 2021
The classic MBSR course, specially tailored for psychedelic therapists.
Oct 4, 2021 - Nov 22, 2021
6:00 - 8:00 PM ET
David Gumpel, MA
Psychedelic Integration: Experiential Training Retreat for Clinicians | Phoenicia, NY
A contemplative practice retreat for clinicians to experience the therapeutic use and integration of non-ordinary states of consciousness.
Oct 19, 2021 - Oct 24, 2021
Time varies
Dr. Elizabeth Nielson, Leah Gooch, Ed.M, 500RYT, Jayne Gumpel, LCSW, Dr. Ingmar Gorman
Psychological Approaches to Psychedelic Therapy, Fall 2021 | Online
A Reading & Study Group teaching focusing on various psychological concepts central to psychedelic therapy.
Sep 17, 2021 - Dec 10, 2021
10:00 - 11:30 AM ET
Andrew Rose
Psychedelics and Psychoanalysis, Fall 2021 | Online
This Reading & Study Group uses contemporary and historical sources to teach the numerous ways psychoanalysis and psychedelics have been, and are, involved with one another.
Sep 22, 2021 - Dec 15, 2021
10:00 - 11:30 AM ET
Dr. Jeffrey Guss
Access and Inclusion in Psychedelic Treatment | Webinar Series
This 10-week webinar series explores the present challenges and future opportunities for addressing social injustice in the field of psychedelic medicine, focusing on the role of the clinician’s voice in context of the larger healthcare system.
Sep 23, 2021 - Dec 9, 2021
7:30 - 8:45 PM ET
Kelly Sykes, PhD, Dr. Elizabeth Nielson, Alexander Camargo, PsyD
Psychoanalytic Psychedelic Clinical Consultation Group, Fall 2021, Section 2 | Online
The goal of this group is to provide a safe, informative and confidential place for therapists and other practitioners to discuss their clinical work in psychedelic integration.
Sep 23, 2021 - Dec 16, 2021
12:00 - 1:30 PM ET
Dr. Jeffrey Guss
Psychedelics Psychopharmacology, Fall 2021 | Online
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Oct 4, 2021 - Dec 20, 2021
8:00 - 9:30 PM ET
Dr. Kelan Thomas
Psychedelic Integration: Experiential Training Retreat for Clinicians | Phoenicia, NY
A contemplative practice retreat for clinicians to experience the therapeutic use and integration of non-ordinary states of consciousness.
Oct 19, 2021 - Oct 24, 2021
Time varies
Dr. Elizabeth Nielson, Leah Gooch, Ed.M, 500RYT, Jayne Gumpel, LCSW, Dr. Ingmar Gorman
Understanding Ketamine Winter | Online
Learn principles for screening and preparing patients for ketamine treatment, and integrating the insights generated from these experiences.
Dec 11, 2021 - Dec 12, 2021
10:00 AM - 5:00 PM EST
Dr. Elizabeth Nielson, Dr. Ingmar Gorman, Dr. Casey Paleos
KAP Theory and Methodology | Winter 2022
A 12-week hybrid course with self-paced materials and weekly live-online meetings teaches a theoretically grounded methodology for KAP.
Jan 12, 2022 - Mar 30, 2022
12:30 PM to 2:00 PM EST
Dr. Ingmar Gorman, Jayne Gumpel, LCSW
Psychological Approaches to Psychedelic Therapy, Fall 2021 | Online
A Reading & Study Group teaching focusing on various psychological concepts central to psychedelic therapy.
Sep 17, 2021 - Dec 10, 2021
10:00 - 11:30 AM ET
Andrew Rose
Psychedelics and Psychoanalysis, Fall 2021 | Online
This Reading & Study Group uses contemporary and historical sources to teach the numerous ways psychoanalysis and psychedelics have been, and are, involved with one another.
Sep 22, 2021 - Dec 15, 2021
10:00 - 11:30 AM ET
Dr. Jeffrey Guss
Access and Inclusion in Psychedelic Treatment | Webinar Series
This 10-week webinar series explores the present challenges and future opportunities for addressing social injustice in the field of psychedelic medicine, focusing on the role of the clinician’s voice in context of the larger healthcare system.
Sep 23, 2021 - Dec 9, 2021
7:30 - 8:45 PM ET
Kelly Sykes, PhD, Dr. Elizabeth Nielson, Alexander Camargo, PsyD
Fluence x Osmind Psychedelic Integration Study | September 23rd Webinar
Recruiting Psychedelic Integration Therapists in the USA. The primary aim of this prospective observational study is to obtain basic information about therapists who provide psychedelic integration, to better understand clients who seek psychedelic integration from these therapists, and whether such patients report improvements in wellbeing and decreases in stigma associated with seeking care.
Sep 23, 2021
6:00 - 7:00 PM EDT
Dr. Ingmar Gorman, Lucia Huang
Psychoanalytic Psychedelic Clinical Consultation Group, Fall 2021, Section 2 | Online
The goal of this group is to provide a safe, informative and confidential place for therapists and other practitioners to discuss their clinical work in psychedelic integration.
Sep 23, 2021 - Dec 16, 2021
12:00 - 1:30 PM ET
Dr. Jeffrey Guss
Psychedelic Integration: Premise and Promise, Fall 2021 | Online
Fluence's foundational course is designed for those who want to learn about Psychedelic Harm Reduction and Integration clinical practice.
Oct 1, 2021 - Oct 3, 2021
10:00 AM - 3:00 PM EDT
Dr. Elizabeth Nielson, Dr. Ingmar Gorman
Psychedelics Psychopharmacology, Fall 2021 | Online
An in-depth look at the pharmacodynamics, pharmacokinetics, pharmacogenomics, and neuroscience of psychedelics.
Oct 4, 2021 - Dec 20, 2021
8:00 - 9:30 PM ET
Dr. Kelan Thomas
Mindfulness Based Stress Reduction for Psychedelic Therapists | Fall 2021
The classic MBSR course, specially tailored for psychedelic therapists.
Oct 4, 2021 - Nov 22, 2021
6:00 - 8:00 PM ET
David Gumpel, MA
Psychedelic Integration: Experiential Training Retreat for Clinicians | Phoenicia, NY
A contemplative practice retreat for clinicians to experience the therapeutic use and integration of non-ordinary states of consciousness.
Oct 19, 2021 - Oct 24, 2021
Time varies
Dr. Elizabeth Nielson, Leah Gooch, Ed.M, 500RYT, Jayne Gumpel, LCSW, Dr. Ingmar Gorman
Understanding Ketamine Winter | Online
Learn principles for screening and preparing patients for ketamine treatment, and integrating the insights generated from these experiences.
Dec 11, 2021 - Dec 12, 2021
10:00 AM - 5:00 PM EST
Dr. Elizabeth Nielson, Dr. Ingmar Gorman, Dr. Casey Paleos
KAP Theory and Methodology | Winter 2022
A 12-week hybrid course with self-paced materials and weekly live-online meetings teaches a theoretically grounded methodology for KAP.
Jan 12, 2022 - Mar 30, 2022
12:30 PM to 2:00 PM EST
Dr. Ingmar Gorman, Jayne Gumpel, LCSW